Your shopping cart is empty!
Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, exceeding 180 brands and more than 350 products by developing its own products as well as working with 30 licensors.
Abdi İbrahim’s product range includes antianemic, antibacterial/antiviral, dermatology, endocrine, metabolism, gastrointestinal, cardiovascular, NSAI and myorelaxants, ophthalmology, central nervous system, respiratory and urogenital system products as well as food supplements, vitamins and minerals from 13 different therapeutic areas.
Abdi İbrahim has taken an important step by signing United Nations Global Principles Agreement in 2010 and given the opportunity to share high standards which it has acquired in the fields of human rights, as well as environmental and social responsibility. Besides, Abdi İbrahim has focused its activities on sustainability studies on level A of Global Reporting Initiative (GRI) and published its third Sustainability Report.
Maintaining its leading position in the Turkish pharmaceutical industry since 2003, Abdi İbrahim increases its effectiveness in international markets with each passing day, with the aim of "becoming one of the top 100 largest pharmaceutical companies in the world" apart from being a wholly local company, as per its vision for 2020.